Schedule 13G ownership disclosure
CENTESSA PHARMACEUTICALS PLC
Security class unavailable · CUSIP: 152309100
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 56,187,791
- Percent of class
- 5.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-24-000208
- Form type
- SC 13G
- Filer
- Centessa Pharmaceuticals plc
- CIK
- CIK 1847903
- Filed
- Feb 14, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership